Meta AnalysisID 2398

表没食子儿茶素没食子酸酯对血糖控制的影响:随机对照试验的Meta分析

CRD42022328143

P: People with different diseases I: intervention by epepigallocatechin gallate C: compared with placebo O:outcomes are glycemic index, fasting glucose, insulin, or glycated hemoglobin (Hb A1c) or HOMA-IR

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2398
Evidence Id
10956
Core Evidence Id
10956
Source Meta Analysis Id
2349
Herb2 Meta Analysis Id
HBMA002349
Crd Id
CRD42022328143
Title
Effects of epigallocatechin gallate on glycemic control: A meta-analyses of randomized controlled trials
Review Question
P: People with different diseases I: intervention by epepigallocatechin gallate C: compared with placebo O:outcomes are glycemic index, fasting glucose, insulin, or glycated hemoglobin (Hb A1c) or HOMA-IR
Study Type Included
Meta-analysis
Condition Being Studied
Diabetes mellitus is a metabolic disorder, defined by abnormally elevated blood glucose, resulting from the defects in insulin secretion or insulin resistance in diabetic patients. Chronic hyperglycemia can cause severe damage to various cells or organs, such as the retina, heart, kidney, and blood vessels in diabetic patients. while most fruits and vegetables, as well as dairy products, have a few amounts of Epigallocatechin‑3‑gallate. Epigallocatechin‑3‑gallate can improve the number and phosphorylation rates of insulin binding receptors and thus facilitated the transportation of glucose into the liver, muscle, and adipose tissue
Participant
diabetes mellitus
Animal
Human Disease Modelled
Intervention
Epigallocatechin gallate
Comparator Control
placebo
Main Outcome
glycemic index” or fasting glucose” or “ insulin” or “glycated hemoglobin” or “Hb A1c “HOMA-IR” or “FBG”
Outcome Measure
Additional Outcome
Study Method
Systematic review
Keyword
Catechin; Glycemic Control; Humans; Randomized Controlled Trials as Topic; epigallocatechin gallate
Contact
Arash karimi [email protected]
Organisational Affiliation
Tabriz University of Medical Sciences, Tabriz, Iran.
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Iran
Review Stage
Review Ongoing
First Submission Date
2022-04-25
Registration Date
2022-05-10
Anticipated Start Date
2022-04-02
Anticipated Completion Date
2022-07-01
Title Cn
表没食子儿茶素没食子酸酯对血糖控制的影响:随机对照试验的Meta分析
Title En
Effects of epigallocatechin gallate on glycemic control: A meta-analyses of randomized controlled trials
Bilingual Status
complete